Abbott's just-announced acquisition of ablation catheter player Kalila Medical reflects the growing adoption of interventional electrophysiology and other devices to treat atrial fibrillation and stroke.
Former Covidien head Jose Almeida, who seized the reins at Baxter at the start of the year, offered an early glimpse of his long-term strategy for the company after spinning off the biopharma Baxalta last year. On a Feb. 2 earnings call, he laid out his priorities as trimming operating expenses, reallocating capital to support innovation and growth, and making smaller acquisitions.
As healthcare providers call for more technology to improve efficiencies, some of the device industry's biggest players are stepping forward with deals aimed at speeding up services and reducing costs.
Hot on the trail of dental device acquisitions, dental implant giants Straumann and Dentsply International are reportedly weighing a deal for Israel's MIS Implants Technologies.
Medtronic has acquired Italian hemodialysis treatment solutions company Bellco from private equity firm Charme Capital Partners, which acquired it in 2012. The medical device giant is folding the acquisition into its newly formed Renal Care Solutions business. This is just the latest in a series of diabetes-related deals for Medtronic, which last year also bought Netherlands-based diabetes clinic and research center Diabeter.
With an eye on earning more recurring revenue, Stryker announced the $2.8 billion acquisition of Sage Products, a maker of disposable devices that reduce the risk of hospital-acquired infections and other adverse events in the intensive care unit.
Over the summer, Abbott said that it was keeping an eye out for potential deals, even if it didn't want one with St. Jude. Now, the company has landed on its next purchase, snatching up diagnostics outfit Alere to bulk up in point-of-care diagnostics and expand its international reach.
Illumina is off to a racing start in 2016, and the pace isn't showing any signs of slowing. The company is snatching up Conexio Genomics to get its hands on Conexio's transplant genotyping products, a couple of weeks after it unveiled its liquid biopsy spinoff and expanded genomics offerings.
Toshiba appears on track to earn more than $3 billion from the sale of its medical device unit to help it recover from an accounting scandal, as the list of companies bidding on Toshiba Medical Systems grows, just prior to the Friday deadline.
Struggling drugmaker MannKind is looking for a way out of its perilous financial situation, according to Reuters, scouting for a buyer in the wake of ex-partner Sanofi's decision to abandon the company and its inhaled insulin.